Unlocking Opportunities in the Respiratory Disease Vaccine Market: Key Trends, Market Growth, and Forecast Insights
2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
What Industry-Specific Factors Are Fueling the Growth of theRespiratory Disease Vaccine Market?
The respiratory disease vaccine market is projected to grow due to the escalating prevalence of tuberculosis. Tuberculosis (TB), colloquially referred to as TB, is a respiratory disease brought on by the bacterium Mycobacterium tuberculosis. Primarily targeting the lungs, it can potentially affect other body organs, causing numerous complications. The surge in tuberculosis cases prompts a push for the development and dissemination of vaccines to minimize the disease’s propagation. The Centers for Disease Control and Prevention, a governmental agency from the US, reported in November 2023 that there were 8,331 TB cases in 2022, a 5.9% rise from 2021. The incidence rate intensified to 2.5 cases per 100,000 population, marking a 5.5% enhancement from the previous year. As such, the augmenting prevalence of tuberculosis is anticipated to fuel the respiratory disease vaccine market. Respiratory Disease Vaccine Market Driver: The Proliferation of Smoking Sparks the Growth of the Respiratory Disease Vaccine Market.
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12924&type=smp
#How Does the ProjectedRespiratory Disease Vaccine Market Growth Compare Over the Forecast Period?
In recent times, the market size for respiratory disease vaccines has seen a slight increase. The market is projected to expand from $69.99 billion in 2024 to $70.9 billion in 2025, reflecting a compound annual growth rate (CAGR) of 1.3%. The growth experienced in the historical timeframe can be linked to the increasing occurrence of respiratory conditions, heightened awareness about vaccinations among the public, initiatives aimed at public health, and a growing demand for vaccines that are effective and easier to tolerate.
Expectations are steady for growth in the respiratory disease vaccine market in the coming years, with projections reaching $79.16 billion by 2029, reflecting a compound annual growth rate (CAGR) of 2.8%. This anticipated growth during the forecast period is largely due to factors such as an aging population, escalating healthcare costs, investments in vaccines and preparation for pandemics. Key trends echoing in the forecast period encompass innovative vaccine introductions, collaborative research initiatives, advancements in vaccine technology and the approval of new drugs.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12924
What Key Market Trends and Innovations Are Shaping the Future of theRespiratory Disease Vaccine Industry?
Major operators in the market for respiratory disease vaccines are focused on crafting cutting-edge products to boost their effectiveness and provide superior solutions for the prevention and treatment of respiratory ailments. For instance, in May 2023, US-based pharmaceutical firm Pfizer Inc. secured approval from the Food and Drug Administration (FDA) for its bivalent RSVpreF vaccine called ABRYSVO (Respiratory Syncytial Virus Vaccine). This is targeted at the prevention of lower respiratory tract infection specifically caused by the respiratory syncytial virus in individuals aged 60 and above. ABRYSVO is an unadjuvanted vaccine, comprising a duo of preF proteins designed to amplify immunity against RSV A and B types. Its clinical trials have confirmed its safety and efficacy.
Which Companies Are Leading the Charge in Expanding theRespiratory Disease Vaccine Market Growth?
Major companies operating in the respiratory disease vaccine market are Pfizer Inc., Johnson & Johnson Ltd., Merck & Co. Inc., Sanofi SA, AstraZeneca PLC, GlaxoSmithKline PLC, Sinovac Biotech Co. Ltd., Moderna Inc., BioNTech SE, CSL Limited, Daiichi Sankyo Company Limited, Mitsubishi Tanabe Pharma Corporation, Novavax Inc., Emergent BioSolutions Inc., Seqirus, Bio Farma, Dynavax Technologies Corporation, Hualan Biological Bacterin Co. Ltd., Serum Institute of India Pvt. Ltd., Bavarian Nordic A/S, Valneva SE, Biological E. Limited, CanSino Biologics Inc., Bharat Biotech International Limited, Medicago Inc., CureVac N.V., Incepta Vaccine Ltd., Inovio Pharmaceuticals Inc., Ology Bioservices, VBI Vaccines Inc.
Order Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/respiratory-disease-vaccine-global-market-report
How is the Global Respiratory Disease Vaccine Market Segemented?
The respiratory disease vaccine market covered in this report is segmented –
1) By Type: Viral Vaccine, Bacterial Vaccine, Combination Vaccine
2) By Infection: COVID-19, Influenza, Respiratory Syncytial Virus (RSV), Pneumonia, Other Infections
3) By Age: Infant, Adolescent, Adult
4) By End-User: Clinic, Hospital, Other End-Users
Subsegments:
1) By Viral Vaccine: Influenza Vaccine, Respiratory Syncytial Virus (RSV) Vaccine, Coronavirus Vaccine
2) By Bacterial Vaccine: Pneumococcal Vaccine, Haemophilus Influenzae Type B (Hib) Vaccine, Pertussis Vaccine
3) By Combination Vaccine: DTaP With Hib And IPV, Pneumococcal Conjugate Vaccine With Influenza Vaccine, MMRV
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=12924&type=smp
Which Geographics are Influencing the Growth of the Respiratory Disease Vaccine Market?
Asia-Pacific was the largest region in the respiratory disease vaccine market in 2024. North America is expected to be the fastest-growing region in the forecast period. The regions covered in respiratory diseases vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Browse Through More Reports Similar to the Global Respiratory Disease Vaccine Market 2025, By The Business Research Company:
Respiratory Devices And Equipment (Therapeutic) Global Market Report 2024
Respiratory Devices And Equipment (Diagnostic) Global Market Report 2024
Respiratory Disposables Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/respiratory-disposables-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
